To discover and develop novel bioactive molecules based on (1) the biological functions of sialic acids and sialylglycans and the interactions with sialic acids and sialylglycans, (2) the biosynthesis and metabolism of sialic acids and sialylglycans.

SiaChem was founded in 2021 as one of the premier companies focusing on the biological functions and biomedical applications of sialic acids and sialylglycans and their biosynthesis and metabolism. The company has established its own research programs and is developing its own intellectual property portfolio. Through its catalog business, SiaChem has also established one of the largest libraries of sialic acids, sialylglycans and their derivatives, reagents and technologies worldwide.

SiaChem makes sialic acids, sialylglycans and their derivatives, and reagents and provides techniques available to all scientists in order to broaden investigations of sialic acids into any field of research and development, such as Cell Biology, Immunology, Neurobiology, Molecular Biology, and Chemical Biology. SiaChem's long-term goal is to use unique sialic acids and sialylglycans and their derivatives and reagents and technologies for researches towards new discoveries of the biological functions of sialic acids and their biosynthesis and metabolism and development of new therapeutic and diagnostic tools.

SiaChem is actively seeking other pharmaceutical and biotech partners and offers a combined range of expertise focusing on the sialochemistry, sialobiology and sialoimmunology area. SiaChem welcomes the opportunity to meet with all interested parties to explore mutually constructive collaborations.